Structure-activity relationship studies of novel heteroretinoids: Induction of apoptosis in the HL-60 cell line by a novel isoxazole-containing heteroretinoid

Journal of Medicinal Chemistry

Volumn 42, Issue 24, 1999, Pages 4961-4969

  Simoni, Daniele ^a   Invidiata, Francesco Paolo ^b   Rondanin, Riccardo ^a   Grimaudo, Stefania ^b   Cannizzo, Giuliana ^b   Barbusca, Eleonora ^b   Porretto, Ferdinando ^b   D'Alessandro, Nicola ^b   Tolomeo, Manlio ^b  

^a UNIVERSITY OF FERRARA   (Italy)

^b UNIVERSITY OF PALERMO   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

ALITRETINOIN; ISOTRETINOIN; ISOXAZOLE DERIVATIVE; RETINOIC ACID; RETINOIC ACID RECEPTOR; RETINOID DERIVATIVE; RETINOID X RECEPTOR;

APOPTOSIS; ARTICLE; CELL DIFFERENTIATION; CELL STRAIN HL 60; CIS TRANS ISOMERISM; CONTROLLED STUDY; CYTOTOXICITY; DRUG ACTIVITY; DRUG STRUCTURE; HUMAN; HUMAN CELL; STRUCTURE ACTIVITY RELATION;

APOPTOSIS; CARBOXYLIC ACIDS; CELL DIFFERENTIATION; GRANULOCYTES; HL-60 CELLS; HUMANS; ISOTRETINOIN; ISOXAZOLES; MOLECULAR STRUCTURE; RECEPTORS, RETINOIC ACID; RETINOIDS; STEREOISOMERISM; STRUCTURE-ACTIVITY RELATIONSHIP; TRETINOIN;

EID: 0033518207     PISSN: 00222623     EISSN: None     Source Type: Journal    
DOI: 10.1021/jm991059n     Document Type: Article

References (33)

1. Kerr, J. F. R.; Wyllie, A. H.; Currie, A. R. Apoptosis: a basic biological phenomenon with wide-ranging implications in tissue kinetics. Br. J. Cancer 1972, 26, 239-257.
2. Martin, S. J.; Green, D. R. Apoptosis and cancer: the failure of controls on cell death and cell survival. Crit. Rev. Oncol. / Hematol. 1995, 18, 137-153.
3. Fisher, D. E. Apoptosis in cancer therapy: crossing the threshold. Cell 1994, 78, 539-542.
4. Kinzler, K. W.; Bogelstein, B. Clinical implications of basic research cancer therapy meets p53. N. Engl. J. Med. 1994, 331, 49-50.
5. Friesen, C.; Herr, I.; Krammer, P. H.; Debatin, K.-M. Involvement of the CD95 (APO-1/Fas) receptor/ligand system in drug-induced apoptosis in leukemia cells. Nat. Med. 1996, 5, 574-577.
6. Tolomeo, M.; Dusonchet, L.; Meli, M.; Grimaudo, S.; D'Alessandro, N.; Papoff, G.; Ruberti, G.; Rausa, L. The CD95/CD95 ligand system is not the major effector in anticancer drug-mediated apoptosis. Cell Death Differ. 1998, 5, 735-742.
7. Delia, D.; Aiello, A.; Lombardi, L.; Pellicci, P. G.; Grignani, F.; Formelli, F.; Menard, S.; Costa, A.; Veronesi, V.; Pierotti, M. A. N-(4-Hydroxypheny)retinamide induces apoptosis of malignant hemopoietic cell lines including those unresponsive to retinoic acid. Cancer Res. 1993, 53, 6036-6041.
8. Yang, Y.; Vacchio, M.; Ashwell, J. D. 9-cis-Retinoic acid inhibits activation-driven T-cell apoptosis: Implications for retinoid X receptor involvement in thymocyte development. Proc. Natl. Acad. Sci. U.S.A. 1993, 90, 6170-6174.
9. Boehm, M. F.; Zhang, L.; Zhi, L.; McClurg, M. R.; Berger, E.; Wagoner, M.; Mais, D. E.; Suto, C. M.; Davies, P. J. A.; Heyman, R. A.; Nadzan, A. M. Design and synthesis of potent retinoid X receptor selective ligands that induce apoptosis in leukemia cells. J. Med. Chem. 1995, 35, 3146-3155.
10. Peck, G. L.; Di Giovanna, J.J. The Retinoids: Biology, Chemistry and Medicine; Raven Press: New York, 1994; pp 631-658.
11. Agarwal, N.; Mehta, K. Possible involvement of Bcl-2 pathway in retinoid X receptor alpha-induced apoptosis of HL-60 cells. Biochem. Biophys. Res. Commun. 1997, 230, 251-253.
12. Ueno, H.; Kizaki, M.; Matsushita, H.; Muto, A.; Yamato, K.; Nishihara, T.; Yoshimura, H.; Koeffler, H. P.; Ikeda, Y. A novel retinoic acid receptor (RAR)-selective antagonist inhibits differentiation and apoptosis of HL-60 cells: implications of RAR alpha-mediated signals in myeloid leukemic cells. Leuk. Res. 1998, 22, 517-525.
13. Monczak, Y.; Trudel, M.; Lamph, W. W.; Miller W. H., Jr. Induction of apoptosis without differentiation by retinoic acid in PLB-985 cells requires the activation of both RAR and RXR. Blood 1997, 90, 3345-3355.
14. Hsu, C. A.; Rishi, A. K.; Su-Li, X.; Gerald, T. M.; Dawson, M. I.; Schiffer, C.; Reichert, U.; Shroot, B.; Poirer, G. C.; Fontana, J. A. Retinoid induced apoptosis in leukemia cells through a retinoic acid nuclear receptor-independent pathway. Blood 1997, 89, 4470-4479.
15. Biro, D. E.; Shalita, A. R. Clinical aspects of topical retinoids. Skin Pharmacol. 1993, 6 (Suppl. 1), 24-34.
16. Shahidallah, M.; Tham, S. N.; Goh, C. L. Isotretinoin therapy in acne vulgaris, a 10 year retrospective study in Singapore. Int. J. Dermatol. 1994, 33, 60-63.
17. Smith, M. A.; Parkinson, D. R.; Cheson, B. D.; Friedman, M. A. Retinoids in cancer therapy. J. Clin. Oncol. 1992,10, 839-864.
18. Yokes, E. E.; Weichselbaum, R. R.; Lippman, S. M.; Hong, W. K. Head and neck cancer. N. Engl. J. Med. 1993, 328, 184-194.
19. Kamm, J. J.; Ashenfelter, K. O.; Ehman, C. W. The Retinoids; Academic Press: New York, 1984; Vol. 2, pp 288-326.
20. Baraldi, P. G.; Barco, A.; Benetti, S.; Guarneri, M.; Manfredini, S.; Pollini, G. P.; Simoni, D. A [3 + 2] nitrile oxide cycloaddition approach to retinoids. Tetrahedron Lett. 1988, 29, 1307-1310.
21. Baraldi, P. G.; Guarneri, M.; Manfredini, S.; Simoni, D.; Tabrizi, M. A.; Barbieri, R.; Gambari, R.; Nastruzzi, C. Synthesis of some isoxazole analogues of retinoids: biological effects toward tumor cell lines. Eur. J. Med. Chem. 1990, 25, 279-284.
22. Manfredini, S.; Simoni, D.; Ferroni, R.; Bazzanini, R.; Vertuani, S.; Hates, S.; De Clercq, E.; Balzarini, J. Retinoic acid conjugates as potential antitumor agents. Synthesis and biological activity of conjugates with ARA-A, ARA-C, the 3(2H)furanone and aniline mustard moieties. J. Med. Chem. 1997, 40, 3581-3857.
23. Manfredini, S.; Simoni, D.; Caminiti, G.; Vertuani, S.; Invidiata, F. P.; Moscato, B.; Hates, S.; De Clercq, E.; Balzarini, J. Retinoids as potential chemotherapeutic agents. Synthesis, cytostatic and differentiating activities of new heterocyclic analogues of retinoic acid. Med. Chem. Res. 1998, 8:6, 291-304.
24. Lepage, F.; Tombret, F.; Cuvier, G.; Marivain, A.; Gllardin, J. M. New N-aryl isoxazolecarboxamides and N-isoxazolylbenzamides as anticonvulsant agents. Eur. J. Med. Chem. 1992, 27, 581-593.
25. Kozikowski, A. P.; Adamczyk, M. Methods for the stereoselective cis cyanohydroxylation and carboxylation of olefins. J. Org. Chem. 1983, 48, 366-372.
26. Loeliger, P.; Bollag, W.; Mayer, H. Arotinoids, a new class of highly active retinoids. J. Med. Chem. Chim. Ther. 1980, 15, 9-15.
27. Dawson, M. I.; Chen, R. L.-S.; Derzinski, K.; Hobbs, P.; Chao, W.-R. Conformationally restricted retinoids. J. Med. Chem. 1984, 27, 1516-1531.
28. Waugh, K. M.; Berlin, K. D.; Ford, W. T.; Holt, E. M.; Carrol, J. P.; Schomber, P. R.; Thompson, M. D.; Schiff, L. J. Synthesis and characterization of selected heteroretinoids. Pharmacological activity as assessed in Vitamin A deficient hamster tracheal organ cultures. Single-crystal X-ray diffraction analysis of 4,4-dimethylthiochroman-6-yl methyl ketone 1,1-dioxide and ethyl (E)-p-[2-(4,4-dimethylthiochroman-6-yl)propenyl]benzoate. J. Med. Chem. 1985, 28, 116-124.
29. Martin, S. J.; Bradley, J. G.; Cotter, T. J. HL-60 cells induced to differentiate towards neutrophils subsequently die via apoptosis. Clin. Exp. Immunol. 1990, 79, 448-453.
30. 31 Our data show that the cytotoxic activity of 14b (Figure 3a) is correlated prevalently with its ability to induce apoptosis in HL-60 cells (Figure 3b).
31. Raffray, M.; Cohen, G. M. Apoptosis and necrosis in toxicology: a continuum or distinct modes of cell death? Pharmacol. Ther. 1997, 75, 153-177.
32. Data not shown.
33. Beard, R. L.; Colon, D. F.; Klein, E. S.; Vorse, K. A.; Chandraratna, R. A. S. Differential RXR & RAR activity of stilbene retinoid analogues bearing thiazole and imidazole carboxylic acids. Bioorg. Med. Chem. Lett. 1995, 5, 2729-2734 and references therein.